Literature DB >> 11865110

Bartter syndrome type 3: an unusual cause of nephrolithiasis.

Giacomo Colussi, Maria Elisabetta De Ferrari, Silvana Tedeschi, Silvia Prandoni, Marie Louise Syrén, Giovanni Civati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11865110     DOI： 10.1093/ndt/17.3.521

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  6 in total

Review 1.  Nephrolithiasis secondary to inherited defects in the thick ascending loop of henle and connecting tubules.

Authors:  Nicolas Faller; Nasser A Dhayat; Daniel G Fuster
Journal:  Urolithiasis       Date:  2018-11-20       Impact factor: 3.436

2.  Gitelman or Bartter type 3 syndrome? A case of distal convoluted tubulopathy caused by CLCNKB gene mutation.

Authors:  António José Cruz; Alexandra Castro
Journal:  BMJ Case Rep       Date:  2013-01-22

Review 3.  Personalized Intervention in Monogenic Stone Formers.

Authors:  Lucas J Policastro; Subodh J Saggi; David S Goldfarb; Jeffrey P Weiss
Journal:  J Urol       Date:  2017-10-20       Impact factor: 7.450

4.  Mutation spectrum of Chinese patients with Bartter syndrome.

Authors:  Yue Han; Yi Lin; Qing Sun; Shujuan Wang; Yanxia Gao; Leping Shao
Journal:  Oncotarget       Date:  2017-09-27

5.  Poor phenotype-genotype association in a large series of patients with Type III Bartter syndrome.

Authors:  Alejandro García Castaño; Gustavo Pérez de Nanclares; Leire Madariaga; Mireia Aguirre; Álvaro Madrid; Sara Chocrón; Inmaculada Nadal; Mercedes Navarro; Elena Lucas; Julia Fijo; Mar Espino; Zilac Espitaletta; Víctor García Nieto; David Barajas de Frutos; Reyner Loza; Guillem Pintos; Luis Castaño; Gema Ariceta
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

6.  Bartter Syndrome Type 3: Phenotype-Genotype Correlation and Favorable Response to Ibuprofen.

Authors:  Xuejun Yang; Gaofu Zhang; Mo Wang; Haiping Yang; Qiu Li
Journal:  Front Pediatr       Date:  2018-05-30       Impact factor: 3.418
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.